Holly Sheffield

Managing Director, Global Head of Medtech

Holly Sheffield

Managing Director, Global Head of Medtech


Holly Sheffield is the Managing Director, Global Head of Medtech. She joined UBS in 2009 from Credit Suisse where she was responsible for global Medical Device Investment Banking. She joined Credit Suisse following the merger with Donaldson, Lufkin & Jenrette in 2000, joining DLJ in 1997. Holly received her MBA from Columbie Business School and her BS from Cornell University.

Selected Transaction Experience:

  • Obalon Therapeutics’ $75 million IPO

  • DJO’s $1,155 million senior secured credit facility, $1,045 million second lien senior secured notes and

    $300 million third lien exchange notes

  • Quotient Limited’s Distribution and Supply Agreement with Ortho-Clinical Diagnostics

  • Genstar Capital / Tecomet’s $450 million acquisition of Symmetry Medical’s OEM Solutions business

  • $565 million financing for GTCR / Sterigenics’ acquisition of Nordion

  • Sale of Bayer’s Interventional Devices business to Boston Scientific for $415 million

  • Financing for Golden Gate Capital’s $765 million acquisition of Phillips-Medisize

  • Quotient Limited’s $40 million IPO

  • Accellent’s $390 million acquisition of Lake Region Medical and related $1.13 billion financing

  • Financing for Carlyle’s $4.15 billion acquisition of JNJ’s Ortho-Clinical Diagnostics

All session by Holly Sheffield